Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination

A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (H...

Full description

Saved in:
Bibliographic Details
Published inMultiple sclerosis Vol. 14; no. 5; pp. 577 - 594
Main Authors Hebb, ALO, Moore, CS, Bhan, V, Campbell, T, Fisk, JD, Robertson, HA, Thorne, M, Lacasse, E, Holcik, M, Gillard, J, Crocker, SJ, Robertson, GS
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.06.2008
Arnold
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN1352-4585
1477-0970
DOI10.1177/1352458507087468

Cover

Abstract A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (HIAP-2), neuronal apoptosis inhibitory protein (NAIP) and Survivin in relapsing–remitting, secondary-progressive, primary-progressive or benign forms of MS is unclear. We report here that expression of the IAP family of genes in peripheral blood samples and brain tissues from MS cases support a role for differential regulation of these potent anti-apoptotic proteins in the pathology of MS. XIAP mRNA and protein levels were elevated in peripheral blood mononuclear cells from patients with active disease relative to normal subjects. In patients with active MS, HIAP-1 and HIAP-2 mRNA levels were elevated in resting T cells while NAIP mRNA was increased in whole blood. In post-mortem MS brain tissue, XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells, respectively. Only in primary-progressive patients was Survivin expression elevated suggestive of a distinct pathological basis for this subtype of MS. Taken together, these results suggest that patterns of inhibitor of apoptosis expression in immune cells may have value in distinguishing between MS subtypes and offer insight into the mechanisms responsible for their distinct clinical courses.
AbstractList A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (HIAP-2), neuronal apoptosis inhibitory protein (NAIP) and Survivin in relapsing-remitting, secondary-progressive, primary-progressive or benign forms of MS is unclear. We report here that expression of the IAP family of genes in peripheral blood samples and brain tissues from MS cases support a role for differential regulation of these potent anti-apoptotic proteins in the pathology of MS. XIAP mRNA and protein levels were elevated in peripheral blood mononuclear cells from patients with active disease relative to normal subjects. In patients with active MS, HIAP-1 and HIAP-2 mRNA levels were elevated in resting T cells while NAIP mRNA was increased in whole blood. In post-mortem MS brain tissue, XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells, respectively. Only in primary-progressive patients was Survivin expression elevated suggestive of a distinct pathological basis for this subtype of MS. Taken together, these results suggest that patterns of inhibitor of apoptosis expression in immune cells may have value in distinguishing between MS subtypes and offer insight into the mechanisms responsible for their distinct clinical courses.A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (HIAP-2), neuronal apoptosis inhibitory protein (NAIP) and Survivin in relapsing-remitting, secondary-progressive, primary-progressive or benign forms of MS is unclear. We report here that expression of the IAP family of genes in peripheral blood samples and brain tissues from MS cases support a role for differential regulation of these potent anti-apoptotic proteins in the pathology of MS. XIAP mRNA and protein levels were elevated in peripheral blood mononuclear cells from patients with active disease relative to normal subjects. In patients with active MS, HIAP-1 and HIAP-2 mRNA levels were elevated in resting T cells while NAIP mRNA was increased in whole blood. In post-mortem MS brain tissue, XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells, respectively. Only in primary-progressive patients was Survivin expression elevated suggestive of a distinct pathological basis for this subtype of MS. Taken together, these results suggest that patterns of inhibitor of apoptosis expression in immune cells may have value in distinguishing between MS subtypes and offer insight into the mechanisms responsible for their distinct clinical courses.
A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (HIAP-2), neuronal apoptosis inhibitory protein (NAIP) and Survivin in relapsing–remitting, secondary-progressive, primary-progressive or benign forms of MS is unclear. We report here that expression of the IAP family of genes in peripheral blood samples and brain tissues from MS cases support a role for differential regulation of these potent anti-apoptotic proteins in the pathology of MS. XIAP mRNA and protein levels were elevated in peripheral blood mononuclear cells from patients with active disease relative to normal subjects. In patients with active MS, HIAP-1 and HIAP-2 mRNA levels were elevated in resting T cells while NAIP mRNA was increased in whole blood. In post-mortem MS brain tissue, XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells, respectively. Only in primary-progressive patients was Survivin expression elevated suggestive of a distinct pathological basis for this subtype of MS. Taken together, these results suggest that patterns of inhibitor of apoptosis expression in immune cells may have value in distinguishing between MS subtypes and offer insight into the mechanisms responsible for their distinct clinical courses.
A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apoptosis-1 (HIAP-1), human inhibitor of apoptosis-2 (HIAP-2), neuronal apoptosis inhibitory protein (NAIP) and Survivin in relapsing-remitting, secondary-progressive, primary-progressive or benign forms of MS is unclear. We report here that expression of the IAP family of genes in peripheral blood samples and brain tissues from MS cases support a role for differential regulation of these potent anti-apoptotic proteins in the pathology of MS. XIAP mRNA and protein levels were elevated in peripheral blood mononuclear cells from patients with active disease relative to normal subjects. In patients with active MS, HIAP-1 and HIAP-2 mRNA levels were elevated in resting T cells while NAIP mRNA was increased in whole blood. In post-mortem MS brain tissue, XIAP and HIAP-1 in myelin lesions were co-localized with microglia and T cells, respectively. Only in primary-progressive patients was Survivin expression elevated suggestive of a distinct pathological basis for this subtype of MS. Taken together, these results suggest that patterns of inhibitor of apoptosis expression in immune cells may have value in distinguishing between MS subtypes and offer insight into the mechanisms responsible for their distinct clinical courses. [PUBLICATION ABSTRACT]
Author Robertson, HA
Holcik, M
Moore, CS
Bhan, V
Lacasse, E
Campbell, T
Hebb, ALO
Thorne, M
Crocker, SJ
Fisk, JD
Gillard, J
Robertson, GS
Author_xml – sequence: 1
  givenname: ALO
  surname: Hebb
  fullname: Hebb, ALO
  organization: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
– sequence: 2
  givenname: CS
  surname: Moore
  fullname: Moore, CS
  organization: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
– sequence: 3
  givenname: V
  surname: Bhan
  fullname: Bhan, V
  organization: Department of Medicine (Neurology), Dalhousie University, Halifax, NS, B3H 1V7, Canada
– sequence: 4
  givenname: T
  surname: Campbell
  fullname: Campbell, T
  organization: Department of Medicine (Neurology), Dalhousie University, Halifax, NS, B3H 1V7, Canada
– sequence: 5
  givenname: JD
  surname: Fisk
  fullname: Fisk, JD
  organization: Department of Psychiatry, Dalhousie University, Halifax, NS, B3H 2E2, Canada; Department of Psychology, QEII Health Sciences Centre, Halifax, NS, B3H 2E2, Canada
– sequence: 6
  givenname: HA
  surname: Robertson
  fullname: Robertson, HA
  organization: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
– sequence: 7
  givenname: M
  surname: Thorne
  fullname: Thorne, M
  organization: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
– sequence: 8
  givenname: E
  surname: Lacasse
  fullname: Lacasse, E
  organization: Aegera Therapeutics Inc., Nun’s Island (Montreal), PQ, H3E 1A8, Canada
– sequence: 9
  givenname: M
  surname: Holcik
  fullname: Holcik, M
  organization: Apoptosis Research Centre, Children's Hospital of Eastern Ontario, Ottawa, Ontario, KIH 8L1, Canada
– sequence: 10
  givenname: J
  surname: Gillard
  fullname: Gillard, J
  organization: Aegera Therapeutics Inc., Nun’s Island (Montreal), PQ, H3E 1A8, Canada
– sequence: 11
  givenname: SJ
  surname: Crocker
  fullname: Crocker, SJ
  organization: Molecular and Integrative Neuroscience Department, the Scripps Research Institute, La Jolla, CA, 92037, USA
– sequence: 12
  givenname: GS
  surname: Robertson
  fullname: Robertson, GS
  organization: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 1X5, Canada; Department of Psychiatry, Dalhousie University, Halifax, NS, B3H 2E2, Canada
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20474420$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18566024$$D View this record in MEDLINE/PubMed
BookMark eNqF0ktvFSEUB3BiauxD964MMdHdKDA8hqVp6iNp4kbXEy6caWkYGIEx3m_jR5X7sCZNGldDht__hHPgHJ3EFAGhl5S8o1Sp97QXjItBEEUGxeXwBJ1RrlRHtCInbd22u93-KTov5Y4QolQvnqFTOggpCeNn6PfVryVDKT5FnCZcbwH7eOs3vqa8-2GWtNRUfMFLThV8xJOZfdg2hec1VL8EwMUGyHuU4SeYULDBS9OxehOwn-c1pjm5NZhWdYtzahm3Zh9vsFlr2gPAMzhvKjjsYN5C8NHUdqrn6OnUKsKL4_cCff949e3yc3f99dOXyw_XneWE184yLRi1Uig-MUs01Ryc0447QaUmvRDWSj1ZI6WkCvre6V5PDjgzm5Y0_QV6e6jb-vyxQqnj7IuFEEyEtJZRasbbbPV_ISMD69mwg68fwLu05tiaGBkdBsnkHr06onXTBjAu2c8mb8e_N9TAmyMwxZowZROtL_eOEa44Z6Q5eXC23UTJMI3W1_0EazY-jJSMuyczPnwyLUgeBO_P8HikO0SKuYF_XT3q_wByCNHc
CODEN MUSCFZ
CitedBy_id crossref_primary_10_1016_j_celrep_2022_110462
crossref_primary_10_1007_s11064_019_02865_7
crossref_primary_10_1371_journal_pone_0005761
crossref_primary_10_4061_2011_485752
crossref_primary_10_1016_j_jneuroim_2015_08_016
crossref_primary_10_1038_srep10191
crossref_primary_10_15430_JCP_2017_22_2_62
crossref_primary_10_1016_j_imlet_2017_11_004
crossref_primary_10_1021_acs_chemrev_1c00716
crossref_primary_10_1517_17460441_2011_573783
crossref_primary_10_1016_j_jneuroim_2008_06_030
crossref_primary_10_1016_j_jneuroim_2011_12_026
crossref_primary_10_1242_jcs_223826
crossref_primary_10_1186_s12865_019_0312_1
crossref_primary_10_1111_cei_12895
crossref_primary_10_1016_j_pathol_2022_07_017
crossref_primary_10_1007_s10495_018_1448_9
crossref_primary_10_1371_journal_pone_0102231
crossref_primary_10_1038_srep39981
crossref_primary_10_1177_1179573519894955
crossref_primary_10_3389_fimmu_2022_839945
crossref_primary_10_1007_s10735_020_09928_y
crossref_primary_10_1016_j_msard_2020_102303
crossref_primary_10_4049_jimmunol_2000482
crossref_primary_10_1016_j_cellsig_2013_06_003
crossref_primary_10_1016_j_lfs_2023_122260
crossref_primary_10_1016_j_neulet_2013_12_070
crossref_primary_10_1177_0300985811429314
crossref_primary_10_1155_2011_809765
Cites_doi 10.1212/WNL.55.7.906
10.1111/j.1600-0404.1996.tb00182.x
10.1023/B:JOCI.0000018057.89066.c6
10.1046/j.0953-816x.2001.01653.x
10.1038/sj.leu.2402779
10.1111/j.1365-2990.1982.tb00308.x
10.1016/j.jneuroim.2006.06.024
10.1016/S0165-2478(01)00186-9
10.4049/jimmunol.174.8.5124
10.1038/sj.onc.1207101
10.1002/glia.1103
10.1182/blood.V79.6.1553.1553
10.1191/1352458503ms890cr
10.1093/brain/120.8.1447
10.1023/A:1011379307472
10.1042/BJ20031506
10.1126/science.3840606
10.1038/379349a0
10.1126/science.290.5497.1779
10.1007/s00251-002-0429-9
10.1096/fj.04-2599fje
10.1084/jem.184.6.2361
10.1016/S0074-7742(07)79006-2
10.1093/brain/awh641
10.1093/brain/awl152
10.1016/S0967-5868(02)00270-9
10.2741/2144
10.1093/brain/awl179
10.1002/ana.1032
10.1093/brain/awl206
10.4049/jimmunol.173.10.6338
10.1016/0092-8674(95)90461-1
10.1191/135248506ms1304rr
10.1034/j.1399-0004.2000.570212.x
10.1182/blood-2002-10-3056
10.1016/j.brainresrev.2004.06.006
10.1097/00001756-200001170-00003
10.1002/glia.20372
10.1016/j.jneuroim.2004.12.010
10.1016/S0165-5728(01)00365-4
10.1016/j.humpath.2005.09.022
10.1016/j.jaut.2004.03.004
10.1177/135245850100700302
10.1016/S0140-6736(05)60642-3
10.1074/jbc.M510863200
10.1093/hmg/5.2.257
10.1212/01.wnl.0000253185.03943.66
10.1111/j.1750-3639.2000.tb00262.x
10.1016/j.semcancer.2004.04.002
10.1002/ana.20703
10.1038/nrm830
10.1212/WNL.62.4.601
10.1016/j.nbd.2004.10.007
10.1002/jnr.20488
10.2165/00063030-200519050-00003
10.1101/gr.1053803
10.1136/jnnp.67.2.148
10.4049/jimmunol.179.11.7553
10.1016/S0002-9440(10)63496-7
10.1016/S0165-5728(02)00185-6
10.1038/nm0897-917
10.1016/0952-7915(92)90058-M
10.4049/jimmunol.164.3.1470
10.1182/blood.V98.7.2091
10.1212/WNL.46.4.907
10.1016/j.clineuro.2005.11.010
10.1016/S0022-510X(02)00053-9
10.1006/meth.2001.1262
10.1111/j.1750-3639.2007.00064.x
10.1111/j.1365-2141.2005.05690.x
10.1056/NEJM200009283431307
10.1046/j.1365-3148.1997.d01-10.x
10.1001/archneur.57.8.1183
10.1097/01.shk.0000123512.13212.ca
10.1073/pnas.0308689100
ContentType Journal Article
Copyright 2008 INIST-CNRS
SAGE Publications © Jun 2008
Copyright_xml – notice: 2008 INIST-CNRS
– notice: SAGE Publications © Jun 2008
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
M0R
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1177/1352458507087468
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
AIDS and Cancer Research Abstracts
MEDLINE

ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
EndPage 594
ExternalDocumentID 1516224091
18566024
20474420
10_1177_1352458507087468
10.1177_1352458507087468
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEWN
AAGGD
AAGLT
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABIDT
ABJIS
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADSTG
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AFVCE
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGQPQ
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
EJD
EMOBN
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
N9A
O9-
P.B
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SASJQ
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
AJGYC
CITATION
AAEJI
AAPII
AJVBE
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7U9
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
AJHME
PUEGO
7X8
ID FETCH-LOGICAL-c404t-c29521c6574f2c09194edd9d4d51690355cc69fca66617e33d939fde42ab952a3
IEDL.DBID 7X7
ISSN 1352-4585
IngestDate Sun Sep 28 04:45:30 EDT 2025
Sat Sep 27 23:01:40 EDT 2025
Fri Jul 25 08:39:39 EDT 2025
Mon Jul 21 05:55:11 EDT 2025
Mon Jul 21 09:15:10 EDT 2025
Tue Jul 01 05:28:16 EDT 2025
Thu Apr 24 22:53:31 EDT 2025
Tue Jun 17 22:46:41 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords CD3+ cells
brain
lesions
microglia
demyelination
Autoimmunity
Nervous system diseases
Multiple sclerosis
Neuroglia
Central nervous system
Protein
Inflammatory disease
Encephalon
Microglia
Demyelination
Central nervous system disease
Degenerative disease
Apoptosis
Language English
License https://journals.sagepub.com/page/policies/text-and-data-mining-license
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c404t-c29521c6574f2c09194edd9d4d51690355cc69fca66617e33d939fde42ab952a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 18566024
PQID 218862689
PQPubID 38324
PageCount 18
ParticipantIDs proquest_miscellaneous_69241479
proquest_miscellaneous_20823289
proquest_journals_218862689
pubmed_primary_18566024
pascalfrancis_primary_20474420
crossref_citationtrail_10_1177_1352458507087468
crossref_primary_10_1177_1352458507087468
sage_journals_10_1177_1352458507087468
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-06-00
PublicationDateYYYYMMDD 2008-06-01
PublicationDate_xml – month: 06
  year: 2008
  text: 2008-06-00
PublicationDecade 2000
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: London
– name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2008
Publisher SAGE Publications
Arnold
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Arnold
– name: Sage Publications Ltd
References Salvesen GS, Duckett CS 2002; 3
Damiano JS, Newman RM, Reed JC 2004; 173
Todaro M, Zeuner A, Stassi G 2004; 24
Ponomarev E, Shriver L, Maresz K, Dittel B 2005; 81
McDonnell GV, Cabrera-Gomez J, Calne DB, Li DKB, Oger J 2003; 9
Holcik M, Gibson H, Korneluk RG 2001; 6
Crocker SJ, Wigle N, Liston P 2001; 14
Greer JM, Csurhes PA, Cameron KD, McCombe PA, Good MF, Pender MP 1997; 120
Killestein J, Den Drijver BF, Van der Graaff WL, Uitdehaag BMJ, Polman CH, Van Lier RAW 2001; 7
Rinaldi L, Gallo P, Calabrese M 2006; 129
Sayao AL, Devonshire V, Tremlett H 2007; 68
Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL 2003; 163
Reed JC, Doctor K, Rojas A 2003; 13
De Stefano N, Battaglini M, Stromillo ML 2006; 129
Robertson GS, Crocker SJ, Nicholson DW, Schulz JB 2000; 10
Sharief MK, Semra YK 2001; 119
Maurer M, Loserth S, Kolb-Maurer A 2002; 54
Dsouza SD, Bonetti B, Balasingam V 1996; 184
van der Goes A, Boorsma W, Hoekstra K, Montagne L, de Groot CJA, Dijkstra CD 2005; 161
Khoury SJ, Guttmann CRG, Orav EJ, Kikinis R, Jolesz FA, Weiner HL 2000; 57
Kornacker M, Verneris MR, Kornacker B, Scheffold C, Negrin RS 2001; 76
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG 2000; 343
Sharief MK, Noori MA, Zoukos Y 2002; 129
Nachmias B, Ashhab Y, Ben Yehuda D 2004; 14
Vischioni B, van der Valk P, Ing SWS, Kruyt FAE, Rodriguez JA, Giaccone G 2006; 37
Damiano JS, Oliveira V, Welsh K, Reed JC 2004; 381
Fukuda S, Pelus LM 2001; 98
Ambrosini G, Adida C, Altieri DC 1997; 3
O’Neill AJ, Doyle BT, Molloy E 2004; 21
Acarin N, Rio J, Fernandez AL 1996; 93
Pittock SJ, Mayr WT, McClelland RL 2004; 62
McDonald WI, Compston A, Edan G 2001; 50
Chofflon M 2005; 19
Liston P, Fong WG, Korneluk RG 2003; 22
Ouhtit A 2007; 1
Stroncek DF, Clay ME, Smith J, Jaszcz WB, Herr G, McCullough J 1997; 7
Livak KJ, Schmittgen TD 2001; 25
Liston P, Roy N, Tamai K 1996; 379
Nyland H, Mork S, Matre R 1982; 8
Djukic M, Mildner A, Schmidt H 2006; 129
Bernard CCA, Derosbo NK 1992; 4
Jensen J, Langkilde AR, Frederiksen JL, Sellebjerg F 2006; 179
Segal BM, Cross AH 2000; 55
Lublin FD, Reingold SC 1996; 46
Eckelman BP, Salvesen GS 2006; 281
Greer JM, Csurhes PA, Pender MP, McCombe PA 2004; 22
Pari G, Berrada F, Verge G, Karpati G, Nalbantoglu J 2000; 11
Pender MP 1998; 351
Diez E, Yaraghi Z, MacKenzie A, Gros P 2000; 164
Willard HF, Riordan JR 1985; 230
McDonnell GV, Hawkins SA 2002; 199
Zehntner SP, Bourbonniere L, Morris SJ 2005; 115
Martin Y, Valero A, Lopez-Terradas JM, Marsal C, Hernandez-Chico C 2000; 57
Raivich G, Banati R 2004; 46
Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR 2000; 290
de Graaf AO, van Krieken JH, Tonnissen E 2005; 130
Pender MP, Csurhes PA, Wolfe NP 2003; 10
Hawkins SA, McDonnell GV 1999; 67
Roy N, Mahadevan MS, McLean M 1995; 80
Barnett MH, Henderson APD, Prineas JW 2006; 12
Kutzelnigg A, Lucchinetti CF, Stadelmann C 2005; 128
Zehntner SP, Brickman C, Bourbonniere L, Remington L, Caruso M, Owens T 2005; 174
Siva A 2006; 108
Pender MP, Rist MJ 2001; 36
Yuo A, Kitagawa S, Motoyoshi K, Azuma E, Saito M, Takaku F 1992; 79
Lassmann H, Bruck W, Lucchinetti CF 2007; 17
Leone C, Le Pavec G, Meme W 2006; 54
Satoh J, Nakanishi M, Koike F 2005; 18
Skulina C, Schmitt S, Dornmair K, Babbe H, Roers A, Rajewsky K 2004; 101
Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C 1996; 5
Tamm I, Kornblau SM, Segall H 2000; 6
Biswas P, Mantelli B, Sica A 2003; 101
Bechmann I, Goldmann J, Kovac AD 2005; 19
Miranda MB, Dyer KF, Grandis JR, Johnson DE 2003; 17
Ishikawa F, Miyazaki S 2005; 53
Polman CH, Reingold SC, Edan G 2005; 58
atypb9
atypb8
Chofflon M (atypb33) 2005; 19
Feuer R (atypb31) 2003; 163
atypb48
atypb49
atypb44
atypb45
atypb46
atypb47
atypb40
atypb41
atypb42
atypb43
atypb15
atypb59
atypb16
atypb17
atypb18
atypb11
atypb55
atypb12
atypb56
atypb13
atypb57
atypb14
atypb58
atypb1
atypb52
atypb3
atypb53
atypb2
atypb10
atypb5
atypb4
atypb7
atypb6
atypb50
Ishikawa F (atypb51) 2005; 53
atypb19
atypb26
atypb27
atypb28
atypb29
atypb22
atypb66
atypb23
atypb67
atypb24
atypb68
atypb25
atypb69
atypb62
atypb63
atypb20
atypb64
atypb21
atypb65
atypb60
atypb61
Tamm I (atypb54) 2000; 6
atypb37
atypb38
atypb39
atypb77
atypb34
atypb35
atypb36
atypb73
atypb30
atypb74
atypb75
atypb32
atypb76
atypb70
Zehntner SP (atypb78) 2005; 115
atypb71
atypb72
References_xml – volume: 119
  start-page: 350
  year: 2001
  end-page: 357
  article-title: Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
  publication-title: J Neuroimmunol
– volume: 129
  start-page: 224
  year: 2002
  end-page: 231
  article-title: Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
  publication-title: J Neuroimmunol
– volume: 161
  start-page: 12
  year: 2005
  end-page: 20
  article-title: Determination of the sequential degradation of myelin proteins by macrophages.
  publication-title: J Neuroimmunol
– volume: 290
  start-page: 1779
  year: 2000
  end-page: 1782
  article-title: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow.
  publication-title: Science
– volume: 68
  start-page: 496
  year: 2007
  end-page: 500
  article-title: Longitudinal follow-up of ‘benign’ multiple sclerosis at 20 years.
  publication-title: Neurology
– volume: 164
  start-page: 1470
  year: 2000
  end-page: 1477
  article-title: The neuronal apoptosis inhibitory protein (Naip) is expressed in macrophages and is modulated after phagocytosis and during intracellular infection with Legionella pneumophila.
  publication-title: J Immunol
– volume: 93
  start-page: 99
  year: 1996
  end-page: 103
  article-title: Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis.
  publication-title: Acta Neurol Scand
– volume: 12
  start-page: 121
  year: 2006
  end-page: 132
  article-title: The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion.
  publication-title: Mult Scler
– volume: 80
  start-page: 167
  year: 1995
  end-page: 178
  article-title: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular-atrophy.
  publication-title: Cell
– volume: 10
  start-page: 283
  year: 2000
  end-page: 292
  article-title: Neuroprotection by the inhibition of apoptosis.
  publication-title: Brain Pathol
– volume: 163
  start-page: 1379
  year: 2003
  end-page: 1393
  article-title: Coxsackievirus B3 and the neonatal CNS – The roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.
  publication-title: Am J Pathol
– volume: 230
  start-page: 940
  year: 1985
  end-page: 942
  article-title: Assignment of the gene for myelin proteolipid protein to the X-chromosome - implications for X-linked myelin disorders.
  publication-title: Science
– volume: 53
  start-page: 226
  year: 2005
  end-page: 233
  article-title: New biodefense strategies by neutrophils.
  publication-title: Arch Immunol Ther Exp (Warsz)
– volume: 21
  start-page: 512
  year: 2004
  end-page: 518
  article-title: Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proteins during spontaneous and delayed apoptosis.
  publication-title: Shock
– volume: 11
  start-page: 9
  year: 2000
  end-page: 14
  article-title: Immunolocalization of NAIP in the human brain and spinal cord.
  publication-title: Neuroreport
– volume: 8
  start-page: 403
  year: 1982
  end-page: 411
  article-title: Insitu characterization of mononuclear cell infiltrates in lesions of multiple-sclerosis.
  publication-title: Neuropathol Appl Neurobiol
– volume: 184
  start-page: 2361
  year: 1996
  end-page: 2370
  article-title: Multiple sclerosis: Fas signaling in oligodendrocyte cell death.
  publication-title: J Exp Med
– volume: 17
  start-page: 390
  year: 2003
  end-page: 400
  article-title: Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X-L and XIAP in the prolonged survival of monocytic cells.
  publication-title: Leukemia
– volume: 57
  start-page: 1183
  year: 2000
  end-page: 1189
  article-title: Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.
  publication-title: Arch Neurol
– volume: 120
  start-page: 1447
  year: 1997
  end-page: 1460
  article-title: Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
  publication-title: Brain
– volume: 54
  start-page: 1
  year: 2002
  end-page: 8
  article-title: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1+49) alters T-cell activation.
  publication-title: Immunogenetics
– volume: 81
  start-page: 389
  year: 2005
  article-title: Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
  publication-title: J Neurosci Res
– volume: 46
  start-page: 907
  year: 1996
  end-page: 911
  article-title: Defining the clinical course of multiple sclerosis: results of an international survey.
  publication-title: Neurology
– volume: 381
  start-page: 213
  year: 2004
  end-page: 219
  article-title: Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses.
  publication-title: Biochem J
– volume: 351
  start-page: 978
  year: 1998
  end-page: 981
  article-title: Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis.
  publication-title: Lancet
– volume: 36
  start-page: 137
  year: 2001
  end-page: 144
  article-title: Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia.
  publication-title: Glia
– volume: 1
  start-page: 1260
  year: 2007
  end-page: 1270
  article-title: Survivin is not only a death encounter but also a survival protein for invading tumor cells.
  publication-title: Front Biosci
– volume: 24
  start-page: 1
  year: 2004
  end-page: 11
  article-title: Role of apoptosis in autoimmunity.
  publication-title: J Clin Immunol
– volume: 13
  start-page: 1376
  year: 2003
  end-page: 1388
  article-title: Comparative analysis of apoptosis and inflammation genes of mice and humans.
  publication-title: Genome Research
– volume: 79
  start-page: 1553
  year: 1992
  end-page: 1557
  article-title: Rapid priming of human monocytes by human hematopoietic growth-factors – granulocyte-macrophage colony-stimulating factor (Csf), macrophage-Csf, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists.
  publication-title: Blood
– volume: 19
  start-page: 647
  year: 2005
  article-title: Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia.
  publication-title: FASEB J
– volume: 101
  start-page: 4452
  year: 2003
  end-page: 4456
  article-title: Expression of CD4 on human peripheral blood neutrophils.
  publication-title: Blood
– volume: 281
  start-page: 3254
  year: 2006
  end-page: 3260
  article-title: The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases.
  publication-title: J Biol Chem
– volume: 14
  start-page: 231
  year: 2004
  end-page: 243
  article-title: The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
  publication-title: Semin Cancer Biol
– volume: 343
  start-page: 938
  year: 2000
  end-page: 952
  article-title: Medical progress: multiple sclerosis.
  publication-title: New Engl J Med
– volume: 62
  start-page: 601
  year: 2004
  end-page: 606
  article-title: Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
  publication-title: Neurology
– volume: 18
  start-page: 537
  year: 2005
  end-page: 550
  article-title: Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.
  publication-title: Neurobiol Dis
– volume: 55
  start-page: 906
  year: 2000
  end-page: 907
  article-title: Fas(t) track to apoptosis in MS - TNF receptors may suppress or potentiate CNS demyelination.
  publication-title: Neurology
– volume: 58
  start-page: 840
  year: 2005
  end-page: 846
  article-title: Diagnostic criteria for multiple sclerosis: 2005 Revisions to the 'McDonald Criteria'.
  publication-title: Ann Neurol
– volume: 22
  start-page: 8568
  year: 2003
  end-page: 8580
  article-title: The inhibitors of apoptosis: there is more to life than Bcl2.
  publication-title: Oncogene
– volume: 9
  start-page: 204
  year: 2003
  end-page: 209
  article-title: Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions - the subclinical stage of primary progressive multiple sclerosis may last 10 years.
  publication-title: Mult Scler
– volume: 50
  start-page: 121
  year: 2001
  end-page: 127
  article-title: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis.
  publication-title: Ann Neurol
– volume: 25
  start-page: 402
  year: 2001
  end-page: 408
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
  publication-title: Methods
– volume: 17
  start-page: 210
  year: 2007
  end-page: 218
  article-title: The immunopathology of multiple sclerosis: an overview.
  publication-title: Brain Pathol
– volume: 57
  start-page: 154
  year: 2000
  end-page: 156
  article-title: The X-linked IAP gene does not contribute to the clinical phenotype of spinal muscular atrophy.
  publication-title: Clin Genets
– volume: 46
  start-page: 261
  year: 2004
  end-page: 281
  article-title: Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
  publication-title: Brain Res Rev
– volume: 37
  start-page: 78
  year: 2006
  end-page: 86
  article-title: Expression and localization of inhibitor of apoptosis proteins in normal human tissues.
  publication-title: Hum Pathol
– volume: 115
  start-page: S36
  year: 2005
  end-page: S37
  article-title: Apoptosis induction as a therapeutic intervention to eliminate encephallitogenic T cells; Antisense XIAP (AEG35169) in murine models of EAE.
  publication-title: Clin Immunol
– volume: 54
  start-page: 183
  year: 2006
  end-page: 192
  article-title: Characterization of human monocyte-derived microglia-like cells.
  publication-title: Glia
– volume: 130
  start-page: 852
  year: 2005
  end-page: 859
  article-title: Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.
  publication-title: Br J Haematol
– volume: 199
  start-page: 1
  year: 2002
  end-page: 15
  article-title: Primary progressive multiple sclerosis: increasing clarity but many unanswered questions.
  publication-title: J Neurol Sci
– volume: 4
  start-page: 760
  year: 1992
  end-page: 765
  article-title: Multiple-sclerosis – an autoimmune-disease of multifactorial etiology.
  publication-title: Curr Opin Immunol
– volume: 3
  start-page: 917
  year: 1997
  end-page: 921
  article-title: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.
  publication-title: Nature Med
– volume: 19
  start-page: 299
  year: 2005
  end-page: 308
  article-title: Mechanisms of action for treatments in multiple sclerosis – does a heterogeneous disease demand a multi-targeted therapeutic approach?
  publication-title: Biodrugs
– volume: 179
  start-page: 163
  year: 2006
  end-page: 172
  article-title: CD8(+) T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
  publication-title: J Neuroimmunol
– volume: 5
  start-page: 710
  year: 1996
  article-title: Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of (c)BCD541 and SNA phenotype (vol 5, pg 257, 1996).
  publication-title: Hum Mol Genet
– volume: 3
  start-page: 401
  year: 2002
  end-page: 410
  article-title: IAP proteins: blocking the road to death’s door.
  publication-title: Nature Rev Mol Cell Biol
– volume: 108
  start-page: 333
  year: 2006
  end-page: 338
  article-title: The spectrum of multiple sclerosis and treatment decisions.
  publication-title: Clin Neurol Neurosurg
– volume: 174
  start-page: 5124
  year: 2005
  end-page: 5131
  article-title: Neutrophils that infiltrate the central nervous system regulate T cell responses.
  publication-title: J Immunol
– volume: 7
  start-page: 95
  year: 1997
  end-page: 99
  article-title: Comparison of two blood cell separators in collecting peripheral blood stem cell components.
  publication-title: Transfus Med
– volume: 6
  start-page: 253
  year: 2001
  end-page: 261
  article-title: XIAP: apoptotic brake and promising therapeutic target.
  publication-title: Apoptosis
– volume: 379
  start-page: 349
  year: 1996
  end-page: 353
  article-title: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes.
  publication-title: Nature
– volume: 101
  start-page: 2428
  year: 2004
  end-page: 2433
  article-title: Multiple sclerosis: Brain-infiltrating CD8(+) T cells persist as clonal expansions in the cerebrospinal fluid and blood.
  publication-title: PNAS
– volume: 10
  start-page: 63
  year: 2003
  end-page: 66
  article-title: Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis.
  publication-title: J Clin Neurosci
– volume: 129
  start-page: 2008
  year: 2006
  end-page: 2016
  article-title: Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
  publication-title: Brain
– volume: 129
  start-page: 1993
  year: 2006
  end-page: 2007
  article-title: Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
  publication-title: Brain
– volume: 7
  start-page: 145
  year: 2001
  end-page: 150
  article-title: Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
  publication-title: Mult Scler
– volume: 67
  start-page: 148
  year: 1999
  end-page: 152
  article-title: Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 76
  start-page: 169
  year: 2001
  end-page: 173
  article-title: Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.
  publication-title: Immunol Lett
– volume: 173
  start-page: 6338
  year: 2004
  end-page: 6345
  article-title: Multiple roles of CLAN (caspase-associated recruitment domain, leucine-rich repeat, TPI-containing protein) in the and NAIP CIIA HET-E, and mammalian innate immune response.
  publication-title: J Immunol
– volume: 22
  start-page: 345
  year: 2004
  end-page: 352
  article-title: Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
  publication-title: J Autoimmun
– volume: 6
  start-page: 1796
  year: 2000
  end-page: 1803
  article-title: Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
  publication-title: Clin Cancer Res
– volume: 128
  start-page: 2705
  year: 2005
  end-page: 2712
  article-title: Cortical demyelination and diffuse white matter injury in multiple sclerosis.
  publication-title: Brain
– volume: 129
  start-page: 2394
  year: 2006
  end-page: 2403
  article-title: Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice.
  publication-title: Brain
– volume: 14
  start-page: 391
  year: 2001
  end-page: 400
  article-title: NAIP protects the nigrostriatal dopamine pathway in an intrastriatal rat model of Parkinson’s disease.
  publication-title: Eur J Neurosci
– volume: 98
  start-page: 2091
  year: 2001
  end-page: 2100
  article-title: Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.
  publication-title: Blood
– ident: atypb22
  doi: 10.1212/WNL.55.7.906
– ident: atypb45
  doi: 10.1111/j.1600-0404.1996.tb00182.x
– ident: atypb49
  doi: 10.1023/B:JOCI.0000018057.89066.c6
– ident: atypb37
  doi: 10.1046/j.0953-816x.2001.01653.x
– ident: atypb62
  doi: 10.1038/sj.leu.2402779
– ident: atypb69
  doi: 10.1111/j.1365-2990.1982.tb00308.x
– ident: atypb9
  doi: 10.1016/j.jneuroim.2006.06.024
– ident: atypb74
  doi: 10.1016/S0165-2478(01)00186-9
– ident: atypb48
  doi: 10.4049/jimmunol.174.8.5124
– ident: atypb63
  doi: 10.1038/sj.onc.1207101
– ident: atypb13
  doi: 10.1002/glia.1103
– ident: atypb47
  doi: 10.1182/blood.V79.6.1553.1553
– ident: atypb6
  doi: 10.1191/1352458503ms890cr
– ident: atypb44
  doi: 10.1093/brain/120.8.1447
– ident: atypb16
  doi: 10.1023/A:1011379307472
– ident: atypb42
  doi: 10.1042/BJ20031506
– ident: atypb41
  doi: 10.1126/science.3840606
– ident: atypb38
  doi: 10.1038/379349a0
– ident: atypb60
  doi: 10.1126/science.290.5497.1779
– ident: atypb75
  doi: 10.1007/s00251-002-0429-9
– volume: 53
  start-page: 226
  year: 2005
  ident: atypb51
  publication-title: Arch Immunol Ther Exp (Warsz)
– ident: atypb59
  doi: 10.1096/fj.04-2599fje
– ident: atypb14
  doi: 10.1084/jem.184.6.2361
– ident: atypb53
  doi: 10.1016/S0074-7742(07)79006-2
– ident: atypb32
  doi: 10.1093/brain/awh641
– ident: atypb7
  doi: 10.1093/brain/awl152
– ident: atypb46
  doi: 10.1016/S0967-5868(02)00270-9
– ident: atypb73
  doi: 10.2741/2144
– ident: atypb8
  doi: 10.1093/brain/awl179
– ident: atypb25
  doi: 10.1002/ana.1032
– ident: atypb57
  doi: 10.1093/brain/awl206
– ident: atypb21
  doi: 10.4049/jimmunol.173.10.6338
– ident: atypb34
  doi: 10.1016/0092-8674(95)90461-1
– ident: atypb67
  doi: 10.1191/135248506ms1304rr
– ident: atypb36
  doi: 10.1034/j.1399-0004.2000.570212.x
– ident: atypb28
  doi: 10.1182/blood-2002-10-3056
– ident: atypb56
  doi: 10.1016/j.brainresrev.2004.06.006
– ident: atypb39
  doi: 10.1097/00001756-200001170-00003
– ident: atypb58
  doi: 10.1002/glia.20372
– ident: atypb55
  doi: 10.1016/j.jneuroim.2004.12.010
– ident: atypb24
  doi: 10.1016/S0165-5728(01)00365-4
– ident: atypb64
  doi: 10.1016/j.humpath.2005.09.022
– ident: atypb40
  doi: 10.1016/j.jaut.2004.03.004
– ident: atypb43
  doi: 10.1177/135245850100700302
– volume: 6
  start-page: 1796
  year: 2000
  ident: atypb54
  publication-title: Clin Cancer Res
– ident: atypb12
  doi: 10.1016/S0140-6736(05)60642-3
– ident: atypb18
  doi: 10.1074/jbc.M510863200
– ident: atypb35
  doi: 10.1093/hmg/5.2.257
– ident: atypb5
  doi: 10.1212/01.wnl.0000253185.03943.66
– ident: atypb20
  doi: 10.1111/j.1750-3639.2000.tb00262.x
– ident: atypb19
  doi: 10.1016/j.semcancer.2004.04.002
– ident: atypb26
  doi: 10.1002/ana.20703
– ident: atypb17
  doi: 10.1038/nrm830
– ident: atypb4
  doi: 10.1212/WNL.62.4.601
– ident: atypb15
  doi: 10.1016/j.nbd.2004.10.007
– ident: atypb61
  doi: 10.1002/jnr.20488
– volume: 19
  start-page: 299
  year: 2005
  ident: atypb33
  publication-title: Biodrugs
  doi: 10.2165/00063030-200519050-00003
– ident: atypb65
  doi: 10.1101/gr.1053803
– ident: atypb3
  doi: 10.1136/jnnp.67.2.148
– ident: atypb77
  doi: 10.4049/jimmunol.179.11.7553
– volume: 163
  start-page: 1379
  year: 2003
  ident: atypb31
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63496-7
– ident: atypb23
  doi: 10.1016/S0165-5728(02)00185-6
– ident: atypb71
  doi: 10.1038/nm0897-917
– ident: atypb11
  doi: 10.1016/0952-7915(92)90058-M
– ident: atypb52
  doi: 10.4049/jimmunol.164.3.1470
– ident: atypb72
  doi: 10.1182/blood.V98.7.2091
– volume: 115
  start-page: S36
  year: 2005
  ident: atypb78
  publication-title: Clin Immunol
– ident: atypb27
  doi: 10.1212/WNL.46.4.907
– ident: atypb10
  doi: 10.1016/j.clineuro.2005.11.010
– ident: atypb2
  doi: 10.1016/S0022-510X(02)00053-9
– ident: atypb30
  doi: 10.1006/meth.2001.1262
– ident: atypb68
  doi: 10.1111/j.1750-3639.2007.00064.x
– ident: atypb76
  doi: 10.1111/j.1365-2141.2005.05690.x
– ident: atypb1
  doi: 10.1056/NEJM200009283431307
– ident: atypb29
  doi: 10.1046/j.1365-3148.1997.d01-10.x
– ident: atypb70
  doi: 10.1001/archneur.57.8.1183
– ident: atypb50
  doi: 10.1097/01.shk.0000123512.13212.ca
– ident: atypb66
  doi: 10.1073/pnas.0308689100
SSID ssj0007735
Score 2.0125692
Snippet A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis...
SourceID proquest
pubmed
pascalfrancis
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 577
SubjectTerms Adult
Aged
Autoimmunity - genetics
Autoimmunity - immunology
Baculoviral IAP Repeat-Containing 3 Protein
Biological and medical sciences
Blotting, Western
Brain - pathology
Brain - physiology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Demyelinating Diseases - genetics
Demyelinating Diseases - immunology
Demyelinating Diseases - pathology
Female
Gene Expression - immunology
Gene Expression Profiling
Humans
Immunologic Factors - genetics
Immunologic Factors - immunology
Inhibitor of Apoptosis Proteins - genetics
Inhibitor of Apoptosis Proteins - immunology
Inhibitor of Apoptosis Proteins - metabolism
Male
Medical sciences
Microglia - immunology
Microtubule-Associated Proteins - genetics
Microtubule-Associated Proteins - immunology
Microtubule-Associated Proteins - metabolism
Middle Aged
Multiple Sclerosis - genetics
Multiple Sclerosis - immunology
Multiple Sclerosis - pathology
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neoplasm Proteins - genetics
Neoplasm Proteins - immunology
Neoplasm Proteins - metabolism
Neurology
Neuronal Apoptosis-Inhibitory Protein - genetics
Neuronal Apoptosis-Inhibitory Protein - immunology
Neuronal Apoptosis-Inhibitory Protein - metabolism
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Ubiquitin-Protein Ligases
X-Linked Inhibitor of Apoptosis Protein - genetics
X-Linked Inhibitor of Apoptosis Protein - immunology
X-Linked Inhibitor of Apoptosis Protein - metabolism
Title Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination
URI https://journals.sagepub.com/doi/full/10.1177/1352458507087468
https://www.ncbi.nlm.nih.gov/pubmed/18566024
https://www.proquest.com/docview/218862689
https://www.proquest.com/docview/20823289
https://www.proquest.com/docview/69241479
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96ByKI-H290zUPIvhQth9p0zyJyh6HcIeIB_u2pPnAwtn0tl3Q_8Y_9WbSbNcT3dd20qadmeQ3mS9C3tS6TFXJy9gWFgwUIeq4kgVYrcpUmvPCqAJzh88vyrNL9nlZLENsTh_CKrdrol-otVN4Rj6HrQjBdyXed9cxNo1C52rooHGXHKYARLBzA19O9lbCeV7sPJPzFLAGA3QMQl5xhrVV_9iJHnSyh59ix24W_4Kbt0K9_O5z-og8DLCRfhj5_JjcMe0Tcu88OMafkt-LnyGitaXOUkB1tGm_NzXo6xovyM51g-ubnvrCDE1Lx5MNoKLbmELaw6PXngjrOoFcUkk7oG5hFbiiDWaSuB9OY8Mvt_5FMTCRjmmOVG4G5wkM9bkogGMpZqpgtrvn_TNyebr49uksDs0XYsUSNsQqE7Czq7LgzGYKUIVgRmuhmfaeNYApSpXCKgn2T8pNnmuRC6sNy2QNI2X-nBy0rjVHhMoSrmdZInleMcV5rW0CklMYm2qTahWR-ZYRKxUqk2ODjKtVGoqR_826iLybRnRjVY49tLNbvJ0GZAnjjGVJRE62zF4FBe5Xk7hF5PV0FzQP3SmyNW4DJOikzPZRlGDcpowDxYtRhnaTrQBGAzyKyFsUqt17__cVx3sneULuj3EseDr0khwM6415BWBpqGdeJWbk8OPi4svXG6yXFnY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFH4qRQIkhNgKodD6AEgcosnixMkBIQStprTTUyvNbXBsR0QqcZhkBP03_AH-I-9lG4pgbr0mz1n0ts9-G8DLTMe-ikXs5lGOG5Q0zdxERrhrVSbRQkRGRVQ7PDuNp-f80zyab8GvoRaG0ioHm9gaam0VnZFP0BUR-E7Sd9U3l4ZGUXB1mKDRScWxufyOO7b67dFHZO-rIDg8OPswdfuhAq7iHm9cFaTosVQcCZ4HCr1lyo3Wqea6jRih-1UqTnMlEdf7woShTsM014YHMsOVMsTn3oCbnCKMqD5iPu7vPCHCaB0JnfiIbTiicVSqRHDq5fqH57tbyRqZkHfTM_4Fb6-klrXe7vA-3OthKnvfydUD2DLlQ7g16wPxj-DnwY8-g7ZkNmeIIllRfikytA9LuiArWzW2LmrWNoIoStadpCAVG3IYWY2PXrZE1EcK9YBJViF1iVbnghVUuWK_Wk0DxuzyklEiJOvKKplcNbYlMKytfUHczKgyhqrrW1l7DOfXwpcd2C5taZ4CkzFeDwJPijDhSohM5x5KamRyXxtfKwcmAyMWqu-ETgM5LhZ-3_z8b9Y58GZcUXVdQDbQ7l3h7bgg8LjgPPAc2B2YvegNRr0YxduB_fEuajqFb2Rp7ApJKCgabKKIcTPtc4EUTzoZWn9sgrAd4ZgDr0mo1u_931882_iR-3B7ejY7WZwcnR7vwp0uh4ZOpp7DdrNcmRcI1Jpsr1UPBp-vWx9_A7ndUOs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+the+inhibitor+of+apoptosis+protein+family+in+multiple+sclerosis+reveals+a+potential+immunomodulatory+role+during+autoimmune+mediated+demyelination&rft.jtitle=Multiple+sclerosis&rft.au=Hebb%2C+ALO&rft.au=Moore%2C+CS&rft.au=Bhan%2C+V&rft.au=Campbell%2C+T&rft.date=2008-06-01&rft.pub=Sage+Publications+Ltd&rft.eissn=1477-0970&rft.volume=14&rft.issue=5&rft.spage=577&rft_id=info:doi/10.1177%2F1352458507087468&rft.externalDocID=1516224091
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-4585&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-4585&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-4585&client=summon